U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 85

1.
SNV/indel hypermutator phenotype in biallelic RAD51C variant - Fanconi anemia
Roni Zemet, Haowei Du, Tomasz Gambin, James R Lupski, Pengfei Liu, Paweł Stankiewicz
Hum Genet. Author manuscript; available in PMC 2024 Jun 1.
Published in final edited form as: Hum Genet. 2023 Jun; 142(6): 721–733. Published online 2023 Apr 9. doi: 10.1007/s00439-023-02550-4
PMCID:
PMC10996436
AbstractArticlePDF–1.0M
2.
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C
Chunling Hu, Anil Belur Nagaraj, Hermela Shimelis, Gemma Montalban, Kun Y. Lee, Huaizhi Huang, Carolyn A. Lumby, Jie Na, Lisa R. Susswein, Maegan E. Roberts, Megan L. Marshall, Susan Hiraki, Holly LaDuca, Elizabeth Chao, Amal Yussuf, Tina Pesaran, Susan L. Neuhausen, Christopher A. Haiman, Peter Kraft, Sara Lindstrom, Julie R. Palmer, Lauren R. Teras, Celine M. Vachon, Song Yao, Irene Ong, Katherine L. Nathanson, Jeffrey N. Weitzel, Nicholas Boddicker, Rohan Gnanaolivu, Eric C. Polley, Georges Mer, Gaofeng Cui, Rachid Karam, Marcy E. Richardson, Susan M. Domchek, Siddhartha Yadav, Kathleen S. Hruska, Jill Dolinsky, S. John Weroha, Steven N. Hart, Jacques Simard, Jean Yves Masson, Yuan-Ping Pang, Fergus J. Couch
Cancer Res. 2023 Aug 1; 83(15): 2557–2571. Published online 2023 May 30. doi: 10.1158/0008-5472.CAN-22-2319
PMCID:
PMC10390864
AbstractArticlePDF–20M
3.
RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles
Michael A. Longo, Sunetra Roy, Yue Chen, Karl-Heinz Tomaszowski, Andrew S. Arvai, Jordan T. Pepper, Rebecca A. Boisvert, Selvi Kunnimalaiyaan, Caezanne Keshvani, David Schild, Albino Bacolla, Gareth J. Williams, John A. Tainer, Katharina Schlacher
Nat Commun. 2023; 14: 4445. Published online 2023 Jul 24. doi: 10.1038/s41467-023-40096-1
PMCID:
PMC10366140
AbstractArticlePDF–5.2M
4.
Homologous recombination–deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants
Rohit Prakash, Yashpal Rawal, Meghan R. Sullivan, McKenzie K. Grundy, Hélène Bret, Michael J. Mihalevic, Hayley L. Rein, Jared M. Baird, Kristie Darrah, Fang Zhang, Raymond Wang, Tiffany A. Traina, Marc R. Radke, Scott H. Kaufmann, Elizabeth M. Swisher, Raphaël Guérois, Mauro Modesti, Patrick Sung, Maria Jasin, Kara A. Bernstein
Proc Natl Acad Sci U S A. 2022 Sep 20; 119(38): e2202727119. Published online 2022 Sep 13. doi: 10.1073/pnas.2202727119
PMCID:
PMC9499524
AbstractArticlePDF–2.9M
5.
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation
Meghan R. Sullivan, Rohit Prakash, Yashpal Rawal, Weibin Wang, Patrick Sung, Marc R. Radke, Scott H. Kaufmann, Elizabeth M. Swisher, Kara A. Bernstein, Maria Jasin
Cold Spring Harb Mol Case Stud. 2021 Apr; 7(2): a006083. doi: 10.1101/mcs.a006083
PMCID:
PMC8040731
AbstractArticlePDF–1.8M
6.
A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect
Lesa M. Dawson, Kerri N. Smith, Salem Werdyani, Robyn Ndikumana, Cindy Penney, Louisa L. Wiede, Kendra L. Smith, Justin A. Pater, Andrée MacMillan, Jane Green, Sheila Drover, Terry‐Lynn Young, Darren D. O’Rielly
Mol Genet Genomic Med. 2020 Feb; 8(2): e1070. Published online 2019 Nov 28. doi: 10.1002/mgg3.1070
PMCID:
PMC7005661
AbstractArticlePDF–1.5M
7.
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer
Na Li, Simone McInerny, Magnus Zethoven, Dane Cheasley, Belle W X Lim, Simone M Rowley, Lisa Devereux, Norah Grewal, Somayeh Ahmadloo, David Byrne, Jue Er Amanda Lee, Jason Li, Stephen B Fox, Thomas John, Yoland Antill, Kylie L Gorringe, Paul A James, Ian G Campbell
J Natl Cancer Inst. 2019 Dec; 111(12): 1332–1338. Published online 2019 Apr 5. doi: 10.1093/jnci/djz045
PMCID:
PMC6910168
AbstractArticlePDF–823K
8.
Metastatic Prostate Cancer in a RAD51C Mutation Carrier
Bindu R. Potugari, Jessica M Engel, Adedayo A. Onitilo
Clin Med Res. 2018 Dec; 16(3-4): 69–72. doi: 10.3121/cmr.2018.1411
PMCID:
PMC6306144
AbstractArticlePDF–298K
9.
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges, Guido Neidhardt, Nikolaus de Gregorio, Ahmed El-Balat, Felix Hilpert, Werner Meier, Rainer Kimmig, Karin Kast, Jalid Sehouli, Klaus Baumann, Christian Jackisch, Tjoung-Won Park-Simon, Lars Hanker, Sandra Kröber, Jacobus Pfisterer, Heidrun Gevensleben, Andreas Schnelzer, Dimo Dietrich, Tanja Neunhöffer, Mathias Krockenberger, Sara Y. Brucker, Peter Nürnberg, Holger Thiele, Janine Altmüller, Josefin Lamla, Gabriele Elser, Andreas du Bois, Eric Hahnen, Rita Schmutzler
PLoS One. 2017; 12(10): e0186043. Published online 2017 Oct 20. doi: 10.1371/journal.pone.0186043
PMCID:
PMC5650145
AbstractArticlePDF–923K
10.
Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes
Javier Gayarre, Paloma Martín-Gimeno, Ana Osorio, Beatriz Paumard, Alicia Barroso, Victoria Fernández, Miguel de la Hoya, Alejandro Rojo, Trinidad Caldés, José Palacios, Miguel Urioste, Javier Benítez, María J García
Br J Cancer. 2017 Sep 26; 117(7): 1048–1062. Published online 2017 Aug 22. doi: 10.1038/bjc.2017.286
PMCID:
PMC5625680
AbstractArticlePDF–2.1M
11.
Estrogen induces RAD51C expression and localization to sites of DNA damage
Anya Alayev, Rachel S. Salamon, Subrata Manna, Naomi S. Schwartz, Adi Y. Berman, Marina K. Holz
Cell Cycle. 2016; 15(23): 3230–3239. Published online 2016 Oct 18. doi: 10.1080/15384101.2016.1241927
PMCID:
PMC5176134
AbstractArticlePDF–965K
12.
Overexpression of Rad51C splice variants in colorectal tumors
Arjun Kalvala, Li Gao, Brittany Aguila, Tyler Reese, Gregory A. Otterson, Miguel A. Villalona-Calero, Wenrui Duan
Oncotarget. 2015 Apr 20; 6(11): 8777–8787. Published online 2014 Dec 30. doi: 10.18632/oncotarget.3209
PMCID:
PMC4496183
AbstractArticlePDF–968K
13.
RAD51C – a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC)
Kathrin Scheckenbach, Stephan E. Baldus, Vera Balz, Marcel Freund, Petra Pakropa, Christoph Sproll, Karl-Ludwig Schäfer, Martin Wagenmann, Jörg Schipper, Helmut Hanenberg
Oral Oncol. Author manuscript; available in PMC 2014 Nov 13.
Published in final edited form as: Oral Oncol. 2014 Mar; 50(3): 196–199. Published online 2013 Dec 6. doi: 10.1016/j.oraloncology.2013.11.007
PMCID:
PMC4230275
AbstractArticlePDF–123K
14.
Single Nucleotide Polymorphisms in Noncoding Regions of Rad51C Do Not Change the Risk of Unselected Breast Cancer but They Modulate the Level of Oxidative Stress and the DNA Damage Characteristics: A Case-Control Study
Peter Gresner, Jolanta Gromadzinska, Ewa Jablonska, Maciej Stepnik, Oscar Zambrano Quispe, Ewa Twardowska, Wojciech Wasowicz
PLoS One. 2014; 9(10): e110696. Published online 2014 Oct 24. doi: 10.1371/journal.pone.0110696
PMCID:
PMC4208807
AbstractArticlePDF–677K
15.
Utilization of Rad51C promoter for transcriptional targeting of cancer cells
Yan Cao, Yan Xu, Lei Zhang, Zhen Li, Ying Jiang, Xiao Tian, Andrei Seluanov, Vera Gorbunova, Zhiyong Mao
Oncotarget. 2014 Apr; 5(7): 1805–1811. Published online 2014 Feb 19. doi: 10.18632/oncotarget.1792
PMCID:
PMC4039114
AbstractArticlePDF–875K
16.
Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients
Liisa M Pelttari, Riikka Nurminen, Alexandra Gylfe, Lauri A Aaltonen, Johanna Schleutker, Heli Nevanlinna
BMC Cancer. 2012; 12: 552. Published online 2012 Nov 23. doi: 10.1186/1471-2407-12-552
PMCID:
PMC3522023
AbstractArticlePDF–153K
17.
Mutation screening of RAD51C in high-risk breast and ovarian cancer families
Wenping Lu, Xianshu Wang, Hongsheng Lin, Noralane M. Lindor, Fergus J. Couch
Fam Cancer. Author manuscript; available in PMC 2013 Sep 1.
Published in final edited form as: Fam Cancer. 2012 Sep; 11(3): 381–385. doi: 10.1007/s10689-012-9523-9
PMCID:
PMC3418444
AbstractArticlePDF–288K
18.
Distinct Roles of FANCO/RAD51C Protein in DNA Damage Signaling and Repair: IMPLICATIONS FOR FANCONI ANEMIA AND BREAST CANCER SUSCEPTIBILITY
Kumar Somyajit, Shreelakshmi Subramanya, Ganesh Nagaraju
J Biol Chem. 2012 Jan 27; 287(5): 3366–3380. Published online 2011 Dec 13. doi: 10.1074/jbc.M111.311241
Correction in:
J Biol Chem. 2019 Aug 30; 294(35): 13198.
PMCID:
PMC3270991
AbstractArticlePDF–4.5M
19.
RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families
Jessica Clague, Greg Wilhoite, Aaron Adamson, Adam Bailis, Jeffrey N. Weitzel, Susan L. Neuhausen
PLoS One. 2011; 6(9): e25632. Published online 2011 Sep 28. doi: 10.1371/journal.pone.0025632
PMCID:
PMC3182241
AbstractArticlePDF–285K
20.
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer
Kumar Somyajit, Shreelakshmi Subramanya, Ganesh Nagaraju
Carcinogenesis. 2010 Dec; 31(12): 2031–2038. Published online 2010 Oct 15. doi: 10.1093/carcin/bgq210
PMCID:
PMC2994284
AbstractArticlePDF–247K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center